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Background.— The prevalence of coronary ﬁstulas is poorly known
in the pediatric population. However complications are potentially
serious as: heart failure, sudden death, arrhythmias, and endocardi-
tis. In adults, transcatheter closure is an alternative to surgical
treatment. In pediatric populations, few publications exist on the
feasibility and effectiveness of this treatment.
Aim.— To evaluate the feasibility of percutaneous closure of coro-
nary ﬁstulae in pediatrics, the evolution and the occurrence of
complications.
Methods.— Retrospective observational multicentric national study
concerning all patients under 16 who underwent transcatheter
closure of a congenital coronary ﬁstula (complex cardiopathies
excluded).
Results:
Origin Left
coronary (28)
Right
coronary (28)
Double (5)
Drainage site Right atrium
(12)
Right atrium
(12)
Right
ventricle
(4)
Right ventricle
(12)
Right
ventricle
(13)
Pulmonary
artery (1)
Left atrium (2) Pulmonary
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Left atrium
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Pulmonary
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Population.— Sixty-one patients (36 girls, 25 boys), median age
at diagnosis 0.6 years [0—15.4], 3,9 years at procedure [0—16].
Initial signs: precordial murmur (90%), congestive heart failure
(11%), nonspeciﬁc ECG abnormalities (4.9%), left or right ventri-
cular dilatation (31%). Efﬁciency: complete occlusion at hospital
discharge in 82%, ﬁve procedures failures. Complications: no death.
Three transient STEMI, three coil embolization, one ventricular
ﬁbrillation (recovered), one Leg ischemia. Combination therapy:
antiplatelet (46%), mean duration 4.1months. One with AVK treat-
ment then antiplatelet. Evolution: data are available for 43 children
(70%), median follow-up 91 days [min = 0, max = 4824]. At 2 years,
complete occlusion rate was 72.7%± 7.6%.
Five reoperations (three transcatheter, two surgical procedures).
One late recanalization at 17months.
No cardiovascular complication.
Conclusion.— Percutaneous closure of coronary ﬁstulas in the pedi-
atric population appears to be effective and relatively safe.
http://dx.doi.org/10.1016/j.acvd.2013.06.014
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Background.— The EDWARDS VALEO LIFESTENT® is a stainless steel,
premounted, open cell stent. Easy dilation to large diameters and
low proﬁle are advantages in growing children. Radial force is poor.
Methods and results.— Between 4-2011 and 12-2012, 41 VALEO®
stents were placed during 33 procedures, including 30 transcatheter
(group 1) and three peroperative procedures (group 2). Data
were retrospectively analyzed. Median age at implantation was
2.6 years (5 days—23 years), weight 10 kg (2—53). Indications were:
pulmonary artery stenosis (23), pulmonary vein stenosis (1), sub-
hepatic vein thrombosis (1), ductus arteriosus stenting (hybrid
approach) for hypoplastic left heart (6) and for interrupted aortic
arch (2).
In group 1, access was femoral in all except ﬁve (4 jugular, 1
transhepatic). Stent placement was achieved in all but one. Predi-
lation was performed in 14, postdilation in ﬁve. In group 2, stents
were placed during bypass, secured with a single stitch and ﬂared
at the proximal end. Acute complications were hemoptysis (3),
reperfusion edema (1), low cardiac output (2), stent dislodgement
(2) and fractures (2). Median follow-up (n = 28) reached 8.8 months
(1.9—34). Early recatheterization was performed in 19 patients
(median 5months). The stent was redilated in seven patients: three
(group 2) to achieve better wall apposition, one due to intimal
1875-2136/$ — see front matter
466 Poster session
proliferation, two for vessel growth. One postoperative dilation
(group 2) was complicated by acute fracture, requiring additional
postdilation. One ductal stent was completely occluded in a child
with borderline hypoplastic left heart that acquired biventricular
circulation. The other 11 were fully patent. Surgery performed
in six patients (interval 1.9 to 10months), showed completely
endothelialized and patent stents. No ‘late’ obstructive stent frac-
tures were seen on chest X-Ray, CT scan or ﬂuoroscopy performed
in 90% of the patients during follow-up. Predilation was the only
signiﬁcant risk factor for acute complication in univariate analysis.
Conclusion.— The VALEO® stent is a useful stent in growing children.
Low radial force is counter balanced by high ﬂexibility, allowing
implantation in distal and tortuous lesions. Early fractures may
occur. Longer-term follow-up is needed.
http://dx.doi.org/10.1016/j.acvd.2013.06.015
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Background.— Balloon sizing during percutaneous atrial septal
defect (ASD) closure leads to bigger device, extending time
procedure and radiation dose but remains the gold standard.
Real time-3D-TransEsophagealEchocardiography (RT-3D-TEE) allows
diameters and area measures on a 3D view. We assessed the rela-
tionships between the occlusive balloon diameter (BD), area and
diameters measured using 2D- and 3D-TEE. The effect of ASD shape
and the predictive value of the measures in children with ostium
secundum ASD were investigated.
Methods.— From 2011 to 2013, we prospectively enrolled 30 chil-
dren (mean weight 30.9± 12.9 kgs max 64min 18) who underwent
transcatheter closure of an isolated ASD under 3D-TEE (3D-matrix
array 2—7MHz TEE probe and iE33 ultrasound machine Philips®).
ASD diameters were measured by transthoracic echo (TTE), 2D-TEE
and off-line by 3D Multiplanar reconstruction (Qlab software®). ASD
area was also estimated by delineating the outlines of the defect
on the reconstruction software. The shape of the ASD was assessed
visually on the RT-3D-TEE ‘‘en face’’ view and was deﬁned as circu-
lar (n = 16) or ovale (n = 14). An asymmetry index was calculated by
the maximal 3D diameter divided by the minimal 3D diameter (mean
1.4± 0.2min 1 max 1.84). A cut-off of 1.25 was set to distinguish
ovale (n = 8) and circular shape (n = 22).
Results.— The Amplatzer® device number was equal to BD± 1mm
in 23 cases (76.7%) and higher in the remaining cases. Difference
between 3D maximal diameter and BD (2.3mm± 4.2min −9.6 max
12.2, P = 0.0051) was higher in round ASD than in ovale shape
(4.8± 3.5 vs. 1.4± 4.1, P = 0.04). ASD area was well correlated with
BD (r = 0.82, P < 0001). Age, body area, weight, size, and retroaor-
tic rim length were not correlated with the difference between 3D
and BD. After multivariate linear regression analysis, ASD area by
3D delineation was the only signiﬁcant variable for the prediction of
BD: BD (mm) = 4.5*ASD area (cm2) +11. This formula allow a predic-
tion with < 1mm difference with the observed BD in ½ and≤ 2mm
in 2/3 of procedures.
Conclusion.— The relationship between BD and echo parameters are
inﬂuenced by the ASD shape. ASD area estimated by delineation on a
3D view is the most relevant parameter to estimate the BD. It may be
sufﬁcient to guide percutaneous ASD closure without balloon sizing
in children.
http://dx.doi.org/10.1016/j.acvd.2013.06.016
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Tricuspid valve (TV) assessment is essential in various congenital
heart diseases. 2D echo remains the cornerstone of TV annulus
(TVA) measure but is limited by its complex shape. We investigated
in children, the feasibility of 3D-Transthoracic echo (TTE) in TVA
assessment compared with 2D.
Methods.— Diameters of TVA were performed on three 2D sectional
views [parasternal short axis (PSA), apical four chambers (A4C),
parasternal right ventricular inﬂow (PSRVI)]. ‘‘En face view’’ of the
TV was obtained with real time zoom 3D in A4C (3D-matrix array
X7-2, X5-1, X3-1 probes, iE33 Philips®). Off-line measures of maxi-
mal (mTVAd) and minimal (mTVAd) diameters were performed using
multiplanar reconstruction on Qlab® Software. An asymmetric ratio
was calculated (mTVAd/mTVAd).
Results.— Sixty-four children (7.1± 5.4 years; weight 2.2—82 kgs)
with (42.2%) and without (57.8%) cardiopathy were prospectively
included. Feasibility of 3D TV dataset was possible in all cases.
Quality was estimated to be fairly good in 69.8% of cases.
Leaﬂets visualization was possible in all unless in three chil-
dren (95.2%) and was better when 3D data set quality was good
(P < 0.0001) mTVAd was from septal to lateral axis. Pearson Cor-
relations were good between mTVAd, mTVAd and 2D sectional
diameters (r≥ 0.8 in all cases, P < 0.0001). TVA was asymmetric
with a ratio > 1.2 in 43 children (67.2%) without signiﬁcant differ-
ence according to the cardiopathy. Difference between mTVAd and
mTVAd was 10.3± 13.2mm/m2 (P < 0.0001). PSA was higher than
mTVAd (P = 0.001) whereas mTVAd was higher than PRSVI (P < 0.0001)
and closed to A4C although superior (P = 0.03) mTVAd was higher
than A4C when mTVAd < 25mm and the contrary was seen for
mTVAd > 25mm.
Conclusion.— Feasibility of 3D imaging of the tricuspid valve is good
in children with or without cardiopathy. According to 3D TVA diame-
ters, the 2D A4C seems to be the most reliable sectional view, while
the 2D-PSRVI underestimates the TAD. Conversely, the 2D PSA seems
to overestimate TVA compared to 3D measures.
http://dx.doi.org/10.1016/j.acvd.2013.06.017
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Background.— The relation between type 1 diabetes and cardiac
structure and function in children is poor documented. We used
2D speckle strain imaging to investigate whether children and ado-
lescents with type 1 diabetes have early echocardiographic signs
